Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Evotec

Explore full profile

Drug discovery and development for pharma and biotech

Hamburg, GermanyFounded 1993Biotech & Life Sciences
Valuation $610M Market cap · Aug/2026
Revenue $660M Latest reported FY

At a glance

Founded
1993
Headquarters
Hamburg, Germany
Listing
IPO 2012
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Evotec.

See all news

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • 3i Group
  • Max Planck Innovation
  • Max Planck Society
  • Gilde Healthcare
  • Max Planck Institute for the Structure and Dynamics of Matter
Employees mapped 4,749 incl. 97 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 47 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 11 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
25 countries with
team presence
🇩🇪 Germany27.9%
🇫🇷 France27.5%
🇮🇹 Italy19.3%
🇬🇧 United Kingdom18.3%
🇺🇸 United States4.8%
Top 5 of 25 shown
Web traffic by country
110K monthly visits
across markets
🇺🇸 United States15%
🇹🇷 Turkey11.7%
🇩🇪 Germany10.5%
🇬🇧 United Kingdom9.8%
🇩🇰 Denmark7.4%
Top 5 markets shown

Patents

Estimated portfolio value
$43M

63 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Evotec was the backer or acquirer, 2000–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

38 deals across Evotec's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Evotec's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        38 of 38 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Evotec on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Evotec on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.